# Nimodipine

## Nimotop inj 10mg/ 50mL

| TAH Drug Code      | [INIM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INIM){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage.                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Subarachnoid hemorrhage, From ruptured intracranial berry aneurysms prophylaxis: initial, 0.5 mg/hr (hemadynamics unstable patient) to 1mg/hr (15mcg/kg/hr) for 2hr, then slowly titrate to 2mg/hr. (usually start drug within 4 days, then keep therapy for10-14days. if Craniotomy: continue IVD for at least 5 days after craniotomy. Then switch to orally 60mg Q4H for 7 days. treatment: initial, 1mg/hr (15mcg/kg/hr) for 2hr, then slowly titrate to 2mg/hr for 5-14days. after that, switch to orally 60mg Q4H for 7 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Must not be administered to patients with severely impaired liver function                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Hypotension, GI disturbances.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nimodipine-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                         |

## Nimotop F.C 30mg

| TAH Drug Code      | [ONIM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONIM){:target="_blank"}                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage.                                                                        |
| Dosing             | Subarachnoid hemorrhage, From ruptured intracranial berry aneurysms: treatment or prophylaxis: 60mg Q4H for 7 days (1 hour before or 2 hours after meals), after IV infusion Nimotop for 5-14 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                       |
| Contraindications  | Patients with severely impaired liver function (eg, cirrhosis of the liver). In view of its indication area, Nimotop tablet is not used during pregnancy or lactation.                              |
| Adverse Effects    | Hypotension, GI disturbances.                                                                                                                                                                       |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nimodipine-drug-information){:target="_blank"}                                                                                                         |

